|
[1]
|
Intranasal in situ gelling liquid crystal for delivery of resveratrol ameliorates memory and neuroinflammation in Alzheimer's disease
Nanomedicine: Nanotechnology, Biology and Medicine,
2023
DOI:10.1016/j.nano.2023.102689
|
|
|
|
|
[2]
|
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
International Journal of Molecular Sciences,
2023
DOI:10.3390/ijms241411450
|
|
|
|
|
[3]
|
Okadaic Acid-Induced Alzheimer's in Rat Brain: Phytochemical Cucurbitacin E Contributes to Memory Gain by Reducing TAU Protein Accumulation
OMICS: A Journal of Integrative Biology,
2023
DOI:10.1089/omi.2022.0175
|
|
|
|
|
[4]
|
The citrus flavonoid “Nobiletin” impedes STZ-induced Alzheimer’s disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism
Inflammopharmacology,
2023
DOI:10.1007/s10787-023-01292-z
|
|
|
|
|
[5]
|
Regulation of phase I and phase II neurosteroid enzymes in the hippocampus of an Alzheimer’s disease rat model: A focus on sulphotransferases and UDP-glucuronosyltransferases
Steroids,
2022
DOI:10.1016/j.steroids.2022.109035
|
|
|
|
|
[6]
|
Regulation of phase I and phase II neurosteroid enzymes in the hippocampus of an Alzheimer’s disease rat model: A focus on sulphotransferases and UDP-glucuronosyltransferases
Steroids,
2022
DOI:10.1016/j.steroids.2022.109035
|
|
|
|
|
[7]
|
Regulation of phase I and phase II neurosteroid enzymes in the hippocampus of an Alzheimer’s disease rat model: A focus on sulphotransferases and UDP-glucuronosyltransferases
Steroids,
2022
DOI:10.1016/j.steroids.2022.109035
|
|
|
|
|
[8]
|
Insulin Resistance in the Brain: Evidence Supporting a Role for Inflammation, Reactive Microglia, and the Impact of Biological Sex
Neuroendocrinology,
2022
DOI:10.1159/000524059
|
|
|
|
|
[9]
|
Regulation of phase I and phase II neurosteroid enzymes in the hippocampus of an Alzheimer’s disease rat model: A focus on sulphotransferases and UDP-glucuronosyltransferases
Steroids,
2022
DOI:10.1016/j.steroids.2022.109035
|
|
|
|
|
[10]
|
Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer’s disease rat model
Acta Pharmacologica Sinica,
2021
DOI:10.1038/s41401-020-00562-8
|
|
|
|
|
[11]
|
Synthesis, Molecular Docking, and Preliminary Evaluation of 2‐(1,2,3‐Triazoyl)benzaldehydes As Multifunctional Agents for the Treatment of Alzheimer's Disease
ChemMedChem,
2020
DOI:10.1002/cmdc.201900622
|
|
|
|
|
[12]
|
Resveratrol targeting tau proteins, amyloid-beta aggregations, and their adverse effects: An updated review
Phytotherapy Research,
2020
DOI:10.1002/ptr.6732
|
|
|
|
|
[13]
|
Resveratrol targeting tau proteins, amyloid‐beta aggregations, and their adverse effects: An updated review
Phytotherapy Research,
2020
DOI:10.1002/ptr.6732
|
|
|
|
|
[14]
|
Synthesis, Molecular Docking, and Preliminary Evaluation of 2‐(1,2,3‐Triazoyl)benzaldehydes As Multifunctional Agents for the Treatment of Alzheimer's Disease
ChemMedChem,
2020
DOI:10.1002/cmdc.201900622
|
|
|
|
|
[15]
|
Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
Journal of Alzheimer's Disease Reports,
2019
DOI:10.3233/ADR-190125
|
|
|
|
|
[16]
|
A Possible Neurodegeneration Mechanism Triggered by Diabetes
Trends in Endocrinology & Metabolism,
2019
DOI:10.1016/j.tem.2019.07.012
|
|
|
|
|
[17]
|
Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β
Neurochemical Research,
2018
DOI:10.1007/s11064-018-2683-8
|
|
|
|